Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07286188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Jul 2026 to Dec 2026
    • Site contact updated
    v4
  2. Site contact updated
    • Publications: details revised at 6 of 6 entries
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Dec 16, 2025
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this double blinded randomized control trial is to evaluate the impact of misoprostol on fluid deficit during hysteroscopic myomectomies. The main questions it aims to answer are: Is there is difference in fluid deficit in patients who receive misoprostol vs placebo pre operatively for hysteroscopic myomectomies? Participants will be randomized to received 800 mcg of either rectal misoprostol prior to their hysteroscopic myomectomy or 4 tablets of placebo (ZEEBO) prior to their hysteroscopic myomectomy.
Trial Details
NCT Number NCT07286188
Lead Sponsor Northwestern University
Conditions
(from sponsor)		 Fibroids, Uterine, Fluid Deficit, Hysteroscopy / Methods
Related terms Hypovolemia, Leiomyoma
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov